<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Hazenberg, M.P.</title>
    <link>http://repub.eur.nl/res/aut/5720/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Peptidoglycan from sterile human spleen induces T-cell proliferation and inflammatory mediators in rheumatoid arthritis patients and healthy subjects (Article)</title>
      <link>http://repub.eur.nl/res/pub/9627/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVES: Peptidoglycan (PG), a component of Gram-positive bacteria, may
          be involved in rheumatoid arthritis (RA) because of its ability to induce
          production of proinflammatory cytokines, to induce arthritis in rodents,
          and its presence in antigen-presenting cells in RA joints. METHODS: In the
          present study, physiologically relevant PG was able to induce T-cell
          proliferation in peripheral blood and synovial fluid samples of RA
          patients, but the magnitude of the response did not differ from that of
          cells from healthy subjects. In addition, production of cytokines
          associated with RA (interleukins (IL)-1beta, IL-6, IL-8, IL-10, IL-12 and
          tumour necrosis factor alpha) and of the matrix metalloproteinase,
          gelatinase B (MMP-9), was induced in blood and synovial fluid cultures of
          RA patients. CONCLUSION: The fact that PG, which can be found in synovial
          tissues of RA patients is able to induce the production of inflammatory
          mediators supports the hypothesis that PG plays a role in the pathogenesis
          of RA by influencing the inflammatory microenvironment of the joint.</description>
    </item> <item>
      <title>Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis (Article)</title>
      <link>http://repub.eur.nl/res/pub/9687/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>Multiple sclerosis is believed to result from a CD4+ T-cell response
      against myelin antigens. Peptidoglycan, a major component of the
      Gram-positive bacterial cell wall, is a functional lipopolysaccharide
      analogue with potent proinflammatory properties and is conceivably a
      mediator of sterile inflammation. Here we demonstrate that peptidoglycan
      is present within antigen-presenting cells in the brain of multiple
      sclerosis patients. These cells have macrophage and dendritic cell
      characteristics, and are immunocompetent as evidenced by co-expression of
      inflammatory cytokines and co-stimulatory molecules. In addition,
      intrathecal plasma cells specific for peptidoglycan are present in
      multiple sclerosis brain tissue, and antibodies binding peptidoglycan are
      present in CSF during active disease. Peptidoglycan may thus contribute to
      T- and B-cell activity during brain inflammation without a requirement for
      local bacterial replication.</description>
    </item> <item>
      <title>Somatostatin receptor subtype expression in cells of the rat immune system during adjuvant arthritis (Article)</title>
      <link>http://repub.eur.nl/res/pub/9070/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>Somatostatin is a neuropeptide that is widely distributed throughout the
          body. It acts as a neurohormone and a neurotransmitter and may also have
          an immunomodulatory role. The genes for five subtypes of somatostatin
          receptors (sst) have been cloned, suggesting that the diverse effects of
          the peptide might be mediated by different receptors. We are interested in
          studying the role of sst ininflammation, using an animal model. Because of
          the up-regulation of sst expression in inflamed joints in human rheumatoid
          arthritis, we chose rat adjuvant arthritis as an experimental model. In
          order to determine which of the sst subtypes might be important in immune
          modulation, subtype expression in leukocytes isolated from different
          lymphoid tissues of the rat was studied. Also, the expression levels of
          the most abundantly expressed sst mRNAs in leukocytes from spleen and
          blood were compared in rats with adjuvantarthritis and controls, using a
          semi-quantitative approach. Furthermore, the effect of systemic
          administration of a long-acting somatostatin analogue, octreotide, which
          binds selectively to sst subtypes 2 and 5 (sst2 and sst5), on the
          incidence and the severity of rat adjuvant arthritis, was studied. The
          main sst expressed in cells of the rat immune system, both resting and
          activated, were found to be sst3 and sst4. This contrasts with the human
          and murine situations, in which sst2 appears to be the main subtype
          expressed in the immune system. No quantitative differences in sst subtype
          mRNA levels in leukocytes from spleen and blood were found between rats
          with adjuvant arthritis and controls. Finally, no effect of systemic
          administration of octreotide on either the incidence or severity of
          adjuvant arthritis in Lewis rats was found. As octreotide binds
          selectively to sst2 and sst5, the absence of an immunomodulatory effect of
          this analogue in rat adjuvant arthritis corroborates our finding that
          these sst subtypes are not expressed in cells of the rat immune system. In
          conclusion, cells of the rat immune system appear to express a spectrum of
          sst (sst3 and sst4) different from that found in human granulomatous and
          autoimmune disease (mainly sst2). Therefore, the rat adjuvant arthritis
          model appears to be suitable only for studying the immunomodulatory
          effects of somatostatin analogues which have a high affinity for sst3 and
          sst4, but not for studying the immunomodulatory effects of octreotide,
          which has a high affinity only for sst2 and sst5.</description>
    </item> <item>
      <title>Detection of muramic acid in a carbohydrate fraction of human spleen (Article)</title>
      <link>http://repub.eur.nl/res/pub/8556/</link>
      <pubDate>1995-01-01T00:00:00Z</pubDate>
      <description>In previous studies, we showed that peptidoglycan polysaccharides from
          anaerobic bacteria normally present in the human gut induced severe
          chronic joint inflammation in rats. Our hypothesis is that peptidoglycan
          from the gut flora is involved in perpetuation of idiopathic inflammation.
          However, in the literature, the presence of peptidoglycan or subunits like
          muramyl peptides in blood or tissues is still a matter of debate. We were
          able to stain red pulp macrophages in all six available human spleens by
          immunohistochemical techniques using a monoclonal antibody against gut
          flora-derived antigens. Therefore, these human spleens were extracted, and
          after removal of most of the protein, the carbohydrate fraction was
          investigated for the presence of muramic acid, an amino sugar
          characteristic for peptidoglycan. Using three different methods for
          detection of muramic acid, we found a mean of 3.3 mumol of muramic acid
          with high-pressure liquid chromatography, 1.9 mumol with a colorimetric
          method for detection of lactate, and 0.8 mumol with an enzymatic method
          for detection of D-lactate per spleen (D-lactate is a specific group of
          the muramic acid molecule). It is concluded that peptidoglycan is present
          in human spleen not as small muramyl peptides as were previously searched
          for by other investigators but as larger macromolecules probably stored in
          spleen macrophages.</description>
    </item> <item>
      <title>Een studie over muizen met een autochtone en een humane darmflora (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/25900/</link>
      <pubDate>1979-11-28T00:00:00Z</pubDate>
      <description></description>
    </item>
  </channel>
</rss>